Experimental siRNA therapeutic shows promise to reduce an important driver of heart disease risk - News-Medical.Net
While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or "bad" cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease…
While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or "bad" cholesterol, and other lipids, to date there are no approved treatments to … [+4761 chars]
Read More
Other Stories in Business
- L3Harris Technologies Stock: A Steady Course In A Changing World (NYSE:LHX)
- Business First Bancshares, Inc. (BFST) Q1 2025 Earnings Call Transcript
- Business first bancshares outlines margin expansion and disciplined growth amid strong Q1 2025 results (NASDAQ:BFST)
- Procter & Gamble Stock Q3: Despite Challenges In Consumer Consumption, It's A Buy (PG)
- Realme Narzo 80x: Budget Smartphones with Style and Performance
- Realme Narzo 80x: Budget Smartphones with Style and Performance
- The Secret Language of Vending Machines: How Machines “Talk” to Each Other in Silence
- The Secret Language of Vending Machines: How Machines “Talk” to Each Other in Silence
- Q4 Results Today Live Updates: Bajaj Housing Finance, Dalmia Bharat, Tamilnad Mercantile Bank, Tata Consumer Products & other 23 companies to announce Q4 results today, HCL Tech, AU Small Finance surg
